Enzo Life Sciences PKA kinase activity kit
06 May, 2021Enzo Life Sciences' PKA kinase activity kit is a safe, rapid method for screening of inhibitors or activators of PKA and for quantitating PKA activity in partially purified, purified or crude enzyme preparations.
Cayman Chemical cGAS Inhibitor Screening Assay Kit
03 May, 2021Cayman Chemical's cGAS Inhibitor Screening Assay Kit provides a robust and easy-to-use platform for identifying novel inhibitors of human cyclic GMP-AMP (cGAMP) synthase (cGAS), a key enzyme in the innate immune response to pathogenic dsDNA.
PBL VeriKine-HS Human IFN Beta TCM ELISA Kit
15 April, 2021The VeriKine-HS Human Interferon Beta TCM ELISA Kit features sensitive detection and quantification of human interferon beta (IFN-Beta) and provides robust results in tissue culture media (TCM).
Cayman Chemical ACE2 Inhibitor Screening Assay Kit
14 April, 2021Cayman Chemical's ACE2 Inhibitor Screening Assay Kit provides a robust and easy-to-use platform to identify potential inhibitors of human angiotensin-converting enzyme 2 (ACE2), with results in 30 min.
Cancer DNA blood tests validated by researchers
14 April, 2021An international research team has assessed five commercially available assays for tumour DNA sequencing — a fast, cheap and less invasive method to diagnose and monitor cancer.
Fluidic Analytics Fluidity One-W for antibody affinity and concentration in undiluted serum
01 April, 2021Using the Fluidity One-W, measurements to determine the affinity, concentration and neutralisation potential of antibodies can be performed directly in human serum.
Diaclone IL-6 ELISA kits and sets
04 March, 2021Interleukin-6 (IL-6) is a multifunctional cytokine that regulates immune responses, acute phase reactions and hematopoiesis, and may play a central role in host defence mechanisms. Diaclone offers IL-6 ELISA kits and sets.
Cayman Chemical STAT3 TR-FRET kits
03 March, 2021Cayman Chemical's STAT3 TR-FRET kits use a homogeneous TR-FRET assay method for rapid measurement of phosphorylated and/or total STAT3 protein levels in cells.
Bio-Rad Laboratories Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1/S2 4-Plex Panel
01 March, 2021The qualitative multiplex immunoassay kit quickly and efficiently detects IgG antibodies against four SARS-CoV-2 antigens, enabling vaccine developers to determine therapeutic efficacy from development through all clinical phases.
Biosensis Alpha-Synuclein Rapid ELISA Kit: Human
17 February, 2021Finding an assay that measures accurate amounts of α-synuclein from a specific biological sample is often challenging. Biosensis has addressed the need for the quantification of α-synuclein with its rapid ELISA kit for this important target.
Assay kit can help diagnose depression, bipolar
29 January, 2021Scientists claim to have developed the world's first test to accurately predict mood disorders in people, based on levels of a specific protein found in the brain.
AdipoGen Life Sciences FGL1 (human) ELISA Kit
18 December, 2020AdipoGen Life Sciences has developed a highly sensitive (1.8 pg/mL) and specific FGL1 (human) ELISA kit that can be used for the quantitative measurement of FGL1 in serum, plasma and cell culture supernatant samples.
BioAuxilium Thunder TR-FRET cell signalling assays
09 December, 2020BioAuxilium has developed its line of high-quality, fully validated Thunder cell signalling assays based on time-resolved Förster resonance energy transfer (TR-FRET) technology.
Cayman Chemical FSP1 and GPX4 Inhibitor Screening Assay Kits
27 October, 2020Cayman Chemical's ferroptosis suppressor protein 1 (FSP1) and glutathione peroxidase 4 (GPX4) inhibitor screening kits provide a robust and easy-to-use platform for identifying novel inhibitors of human FSP1 and GPX4, which are negative regulators of the ferroptosis pathway.
Leinco Technologies COVID-19 ImmunoRank Neutralization MICRO-ELISA
02 October, 2020Leinco Technologies collaborated with ADMA Biologics to develop the COVID-19 ImmunoRank Neutralization MICRO-ELISA — a 96-well ELISA-based assay for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19.
